$0.14
(Market cap
$222 Mln
Revenue (TTM)
$68 Mln
P/E Ratio
--
P/B Ratio
7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.2 %
-
ROCE
-- %
-
Industry P/E
37.91
-
EV/EBITDA
118
-
Debt to Equity
0.6
-
Book Value
$--
-
EPS
$-0.2
-
Face value
--
-
Shares outstanding
22,224,395
10 Years Aggregate
CFO
$-467.34 Mln
EBITDA
$-730.17 Mln
Net Profit
$-792.73 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Journey Medical Corp (DERM)
| -6.2 | 12.3 | 19.1 | 0.0 | 34.8 | -- | -- |
|
BSE Sensex
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Journey Medical Corp (DERM)
| 97.2 | -31.9 | 200.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Journey Medical Corp (DERM)
|
7.2 | 221.8 | 68.2 | -6.1 | -3.6 | -19.1 | -- | 7.0 |
| 17.0 | 6,074.3 | 3,117.6 | 157.4 | 14.7 | -- | 36.3 | 188.5 | |
| 220.8 | 10,826.1 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 131.0 | |
| 72.4 | 14,630.7 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 112.8 | 12,065.9 | 830.8 | 54.9 | 3.2 | 8.1 | 248 | 17.3 | |
| 11.9 | 9,754.3 | 332,834.2 | 33,166.6 | 11.1 | 8.9 | 28.6 | 2.4 | |
| 23.2 | 11,421.4 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.8 | |
| 284.5 | 5,693.6 | 290.5 | 197.2 | 82.5 | 19.9 | 29.8 | 5.9 | |
| 66.7 | 6,145.7 | 450.9 | 138.6 | 39.1 | 115.6 | 49 | 30.7 | |
| 127.2 | 8,210.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 19.0 |
Shareholding Pattern
View DetailsAbout Journey Medical Corp (DERM)
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed... products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Read more
-
Executive Chairman
Dr. Lindsay Allan Rosenwald
-
Executive Chairman
Dr. Lindsay Allan Rosenwald
-
Headquarters
Scottsdale, AZ
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Journey Medical Corp (DERM)
What is the current share price of Journey Medical Corp (DERM) Today?
The share price of Journey Medical Corp (DERM) is $7.23 (NASDAQ) as of 11-Sep-2026 16:00 EDT. Journey Medical Corp (DERM) has given a return of 34.83% in the last 3 years.
What is the current PB & PE ratio of Journey Medical Corp (DERM)?
Since, TTM earnings of Journey Medical Corp (DERM) is negative, P/E ratio is not available.
The P/B ratio of Journey Medical Corp (DERM) is 6.96 times as on 04-Sep-2026, a 9 discount to its peers’ median range of 7.69 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-16.52 |
5.93 |
2024 |
-5.90 |
4.32 |
2023 |
-28.89 |
5.47 |
2022 |
-1.15 |
2.00 |
2021 |
-1.62 |
1.69 |
What is the 52 Week High and Low of Journey Medical Corp (DERM)?
The 52-week high and low of Journey Medical Corp (DERM) are Rs 9.56 and Rs 4.31 as of 12-Sep-2026.
What is the market cap of Journey Medical Corp (DERM)?
Journey Medical Corp (DERM) has a market capitalisation of $ 222 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Journey Medical Corp (DERM)?
Before investing in Journey Medical Corp (DERM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.